BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2154763)

  • 1. Characterization of [3H] (+)-pentazocine, a highly selective sigma ligand.
    Bowen WD; DeCosta B; Hellewell SB; Thurkauf A; Walker JM; Rice KC
    Prog Clin Biol Res; 1990; 328():117-20. PubMed ID: 2154763
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors.
    de Costa BR; Bowen WD; Hellewell SB; Walker JM; Thurkauf A; Jacobson AE; Rice KC
    FEBS Lett; 1989 Jul; 251(1-2):53-8. PubMed ID: 2568952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain.
    Su TP
    J Pharmacol Exp Ther; 1982 Nov; 223(2):284-90. PubMed ID: 6290634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specific binding of N-allylnormetazocine (SKF 10047), a ligand of sigma-opioid receptors, with liver membranes].
    Samovilova NN; Iarygin KN; Vinogradov VA
    Bioorg Khim; 1985 Oct; 11(10):1380-4. PubMed ID: 3000388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.
    Largent BL; Gundlach AL; Snyder SH
    J Pharmacol Exp Ther; 1986 Aug; 238(2):739-48. PubMed ID: 3016248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An endogenous ligand for the sigma opioid binding site.
    Contreras PC; DiMaggio DA; O'Donohue TL
    Synapse; 1987; 1(1):57-61. PubMed ID: 2850620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric modulation of ligand binding to [3H](+)pentazocine-defined sigma recognition sites by phenytoin.
    DeHaven-Hudkins DL; Ford-Rice FY; Allen JT; Hudkins RL
    Life Sci; 1993; 53(1):41-8. PubMed ID: 8515681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a (+)-azidophenazocine-sensitive sigma receptor on splenic lymphocytes.
    Garza HH; Mayo S; Bowen WD; DeCosta BR; Carr DJ
    J Immunol; 1993 Nov; 151(9):4672-80. PubMed ID: 7691955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of phencyclidine and sigma receptor-binding sites in brain.
    Gundlach AL; Largent BL; Snyder SH
    NIDA Res Monogr; 1986; 64():1-13. PubMed ID: 3012343
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple affinity binding states of the sigma receptor: effect of GTP-binding protein-modifying agents.
    Itzhak Y
    Mol Pharmacol; 1989 Oct; 36(4):512-7. PubMed ID: 2554109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding and analgesic properties of a sigma opiate, SKF 10,047.
    Pasternak GW; Carroll-Buatti M; Spiegel K
    J Pharmacol Exp Ther; 1981 Oct; 219(1):192-8. PubMed ID: 6270299
    [No Abstract]   [Full Text] [Related]  

  • 12. [3H]1-(cyclopropylmethyl)-4-(2-(4-fluorophenyl)-2-oxoethyl) piperidine HBr (DuP 734). A selective ligand for sigma receptors in mouse brain in vivo.
    Watanabe M; Rominger D; Hurt SD; De Souza EB; Tam SW
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1541-8. PubMed ID: 8371156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of non-opioid sigma binding with (d)3H-SKF 10047 in guinea pig brain.
    Mickelson MM; Lahti RA
    Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):255-63. PubMed ID: 2986252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence of phencyclidine/sigma opioid receptor commonality.
    Sircar R; Zukin SR
    NIDA Res Monogr; 1986; 64():14-23. PubMed ID: 3012345
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligand (+)-pentazocine.
    Steinfels GF; Alberici GP; Tam SW; Cook L
    Neuropsychopharmacology; 1988 Dec; 1(4):321-7. PubMed ID: 2855202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3H-SKF10047 receptor binding studies. Attempts to define the opioid sigma receptor.
    Mickelson MM; Lahti RA
    Neuropeptides; 1984 Dec; 5(1-3):149-52. PubMed ID: 6099485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive interactions at [3H]1,3-di(2-tolyl)guanidine (DTG)-defined sigma recognition sites in guinea pig brain.
    DeHaven-Hudkins DL; Fleissner LC
    Life Sci; 1992; 50(9):PL65-70. PubMed ID: 1346920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the binding of [3H](+)-pentazocine to sigma recognition sites in guinea pig brain.
    DeHaven-Hudkins DL; Fleissner LC; Ford-Rice FY
    Eur J Pharmacol; 1992 Dec; 227(4):371-8. PubMed ID: 1359973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain.
    Martin BR; Katzen JS; Woods JA; Tripathi HL; Harris LS; May EL
    J Pharmacol Exp Ther; 1984 Dec; 231(3):539-44. PubMed ID: 6094791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo binding of [3H]d-N-allylnormetazocine and [3H]haloperidol to sigma receptors in the mouse brain.
    Weissman AD; Broussolle EP; London ED
    J Chem Neuroanat; 1990; 3(5):347-54. PubMed ID: 2171560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.